Skip to content

IDEAYA Biosciences, Inc. IDYA Change in Other Assets

Change in Other Assets at other companies

Amgen logo
AmgenAMGN
-$8M-104%
Tango Therapeutics logo
Tango TherapeuticsTNGX
-$10K-900%
Arcus Biosciences logo
Arcus BiosciencesRCUS
$3M
Summit Therapeutics logo
Summit TherapeuticsSMMT
$1.03M-27.7%
Apogee Therapeutics, Inc. logo
Apogee Therapeutics, Inc.APGE
-$155K-102%
Roivant Sciences logo
Roivant SciencesROIV
$1.85M-15.3%

Other financials

Income statement

See full
Revenue$6.6M
Operating income-$108.5M-28.6%
Net income-$98.5M-36.5%
EPS (diluted)-$1.11-35.4%

Balance sheet

See full
Cash & equivalents$157.5M+21.2%
Total debt$28.6M+10.1%
Total equity$937.3M-8.5%
Total assets$1.0B-6.4%

Cash flow

See full
Operating cash flow-$75.2M-24.6%
CapEx$967.0K-27.3%
Free cash flow-$76.1M-23.5%

Valuation

See full
Market cap$3.36B+104%
Enterprise value$3.23B+110%
P/S14.5×+9.9×

Profitability

See full
Operating margin-4,671.1%-5,434pp
Net margin-3,921.1%-4,562pp
FCF margin-3,592%-4,290pp

Returns & leverage

See full
Return on equity-14.3%-5.0pp
Debt / equity0.0×
Current ratio10.7×-3.2×

Where this comes from

Reported directly by IDEAYA Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.

The official record: IDEAYA Biosciences, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about IDEAYA Biosciences, Inc.'s change in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is IDEAYA Biosciences, Inc.'s change in other assets?
IDEAYA Biosciences, Inc. (IDYA) reported change in other assets of -$3.03M in Q1 2026.
How has IDEAYA Biosciences, Inc.'s change in other assets changed year-over-year?
IDEAYA Biosciences, Inc.'s change in other assets decreased by 253.6% year-over-year, from $1.97M to -$3.03M.
What is the long-term trend for IDEAYA Biosciences, Inc.'s change in other assets?
Over 2 years (2022 to 2025), IDEAYA Biosciences, Inc.'s change in other assets has grown at a 94.7% compound annual growth rate (CAGR), from $2.12M to $8.03M.
What does change in other assets mean?
Change in miscellaneous assets affecting operating cash flow.